Clinical Trial Update: Monoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

This ClinicalTrials.gov entry details a Phase 1 study combining monoclonal antibody therapy with chemotherapy and peripheral stem cell transplantation in patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: University of California, Davis | Conditions: Lymphoma | Phase 1 | Status: UNKNOWN